“This year, all our pre-filled syringe COVID-19 vaccine doses for Canada are on track to be produced entirely within the country, starting at our new mRNA manufacturing facility in Laval, Quebec, and completed at our fill-finish partner in Cambridge, Ontario,” Raos says.

“This end-to-end domestic supply chain enables fast delivery, greater self-reliance, and a more agile response to evolving public health threats.”

  • idarknight@lemmy.ca
    link
    fedilink
    arrow-up
    20
    arrow-down
    1
    ·
    3 days ago

    Pre filled eh? Don’t tell Smith that in Alberta… she’ll have to come up with another story to explain vaccines waste.